GIM
XLRN

Granahan Investment Management’s Acceleron Pharma Inc. XLRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-67,888
Closed -$11.7M 205
2021
Q3
$11.7M Sell
67,888
-12,420
-15% -$2.14M 0.22% 103
2021
Q2
$10.1M Buy
80,308
+3,884
+5% +$487K 0.19% 114
2021
Q1
$10.4M Buy
76,424
+17,950
+31% +$2.43M 0.22% 90
2020
Q4
$7.48M Sell
58,474
-58,022
-50% -$7.42M 0.17% 108
2020
Q3
$13.1M Sell
116,496
-17,395
-13% -$1.96M 0.44% 68
2020
Q2
$12.8M Sell
133,891
-12,830
-9% -$1.22M 0.46% 64
2020
Q1
$13.2M Sell
146,721
-64,611
-31% -$5.81M 0.71% 42
2019
Q4
$11.2M Sell
211,332
-3,695
-2% -$196K 0.52% 57
2019
Q3
$8.5M Buy
215,027
+10,583
+5% +$418K 0.47% 65
2019
Q2
$8.4M Sell
204,444
-14,020
-6% -$576K 0.42% 69
2019
Q1
$10.2M Sell
218,464
-14,738
-6% -$686K 0.55% 53
2018
Q4
$10.2M Sell
233,202
-5,177
-2% -$225K 0.72% 47
2018
Q3
$13.6M Buy
238,379
+10,895
+5% +$624K 0.74% 47
2018
Q2
$11M Sell
227,484
-5,262
-2% -$255K 0.67% 48
2018
Q1
$9.1M Buy
232,746
+6,515
+3% +$255K 0.66% 50
2017
Q4
$9.6M Buy
226,231
+9,140
+4% +$388K 0.76% 42
2017
Q3
$8.1M Buy
217,091
+28,694
+15% +$1.07M 0.68% 48
2017
Q2
$5.73M Buy
188,397
+1,305
+0.7% +$39.7K 0.53% 69
2017
Q1
$4.95M Sell
187,092
-493,117
-72% -$13.1M 0.5% 72
2016
Q4
$17.4M Sell
680,209
-136,940
-17% -$3.49M 0.6% 68
2016
Q3
$29.6M Buy
817,149
+57,530
+8% +$2.08M 0.97% 22
2016
Q2
$25.8M Buy
759,619
+37,150
+5% +$1.26M 0.94% 30
2016
Q1
$19.1M Buy
722,469
+66,078
+10% +$1.74M 0.69% 49
2015
Q4
$32M Buy
656,391
+165,955
+34% +$8.09M 1.1% 20
2015
Q3
$12.2M Buy
490,436
+21,400
+5% +$533K 0.38% 97
2015
Q2
$14.8M Sell
469,036
-740
-0.2% -$23.4K 0.42% 86
2015
Q1
$17.9M Buy
469,776
+163,788
+54% +$6.23M 0.51% 71
2014
Q4
$11.9M Buy
+305,988
New +$11.9M 0.35% 105